Patents by Inventor Leif Engmann Kristensen

Leif Engmann Kristensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9501949
    Abstract: The present specification discloses a method, system and program product that can be used for self-management of any chronic disease. The invention involves the use of a device to enter patient's disease related data. Based on this data patient's habits are detected and presented in a graphical format. The user also has the option of setting up a reminder based on the detected habits.
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: November 22, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Jon Ulrich Hansen, Leif Engmann Kristensen, Jette Randlov, Knud Poulsen, Radisch Ulrik Detlef Poulsen, Jens Ulrik Poulsen, Jorgen Slot Smedegaard, Hans Henrik Thodberg
  • Publication number: 20100145262
    Abstract: A closed loop control system for a medical drug delivery device logs historical data such as drug delivered and corresponding physiological parameters such as blood glucose level. On the basis of the logged historical data, the system calculates an estimated event forecast on which basis the system further calculates the necessary, prudent future drug delivery profile in order to counter delay in the closed loop. The estimated event forecast is presented to the user, the user is thereby given the possibility to accept, reject or adjust the event forecast and the corresponding drug delivery profile. Dynamic and adaptive safety limits to the drug delivery and the physiological parameter can be set by the user and will dynamically follow the drug delivery profile and the event forecast and will further optimize based on the learned behavioural pattern of the user. The user can set the safety level as a percentage of deviation to the drug delivery profile.
    Type: Application
    Filed: April 7, 2008
    Publication date: June 10, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Leif Engmann Kristensen, Joergen Smedegaard, Morten Simoni Spjuth, Ole Skyggebjerg
  • Publication number: 20100030092
    Abstract: The onset or presence of a hypoglycaemic condition in a living being is estimated by obtaining ECG signals, which are processed together with secondary input, such as skin impedance, information about a condition of the living being, or blood glucose level, to estimate whether the living being is experiencing or approaching a hypoglycaemic condition. An output alert may be generated. Feedback indicative of a possible misestimate of the onset or presence of the hypoglycaemic condition is received to allow a system incorporating the invention to adapt and personalize to a specific living being. The feedback may influence one or more sensitivity or specificity settings. Settings of the system may be influenced by the location or rate of movement of the living being.
    Type: Application
    Filed: November 14, 2007
    Publication date: February 4, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Leif Engmann Kristensen, Tue Deleuran, Henrik Bengtsson
  • Publication number: 20090036828
    Abstract: The present specification discloses a method, system and program product that can be used for self-management of any chronic disease. The invention involves the use of a device to enter patient's disease related data. Based on this data patient's habits are detected and presented in a graphical format. The user also has the option of setting up a reminder based on the detected habits.
    Type: Application
    Filed: October 6, 2005
    Publication date: February 5, 2009
    Applicant: NOVO NORDISK A/S
    Inventors: Jon Ulrich Hansen, Leif Engmann Kristensen, Jette Randlov, Knud Poulsen, Radisch Ulrik Detlef Poulsen, Jens Ulrik Poulsen, Jorgen Smedegaard Kirstensen, Hans Henrik Thodberg